DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/68bj8d/finland_diabetes) has announced the addition of the "Finland Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018" report to their offering.
"Finland Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018" provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories - Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts.
Key Topics Covered:
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 What is This Report About? 7
3 Diabetes Care Devices In Finland 8
3.1 Diabetes Care Devices, Finland, Overall Revenue ($m) , USD Constant, 2004-2018 8
3.2 Diabetes Care Devices, Finland, Company Share (2010-2011) 14
4 Glucose Monitoring In Finland 16
4.1 Glucose Monitoring Overall Revenue, (2004-2018) 16
4.2 Glucose Monitoring Overall Volume (2004-2018) 24
4.3 Glucose Monitoring Average Price (2004-2018) 30
4.4 Glucose Monitoring Distribution Share (2010-2011) 31
4.5 Glucose Monitoring, Finland, Company Share (2010-2011) 32
5 Insulin Delivery In Finland 34
5.1 Insulin Delivery Overall Revenue, (2004-2018) 34
5.2 Insulin Delivery Overall Volume (2004-2018) 44
5.3 Insulin Delivery Average Price (2004-2018) 54
5.4 Insulin Delivery Distribution Share (2010-2011) 55
5.5 Insulin Delivery, Finland, Company Share (2010-2011) 56
6 Overview of Key Companies in Finland Diabetes Care Devices Market 58
6.1 F. Hoffmann-La Roche Ltd. 58
6.1.1 Company Overview 58
6.2 LifeScan, Inc. 58
6.3 Eli Lilly and Company 59
6.4 Sanofi 59
6.5 Bayer HealthCare AG 60
6.6 Medtronic, Inc. 60
6.7 Abbott Laboratories 61
6.7.1 Company Overview 61
6.8 Novo Nordisk A/S 61
6.9 Becton, Dickinson and Company 62
6.10 Terumo Corporation 62
6.11 Animas Corporation 63
6.12 Ypsomed Holding AG 63
6.13 Nipro Corporation 63
7 Appendix 64
7.1 Global Markets Direct Research Methodology 64
7.2 Definitions of Markets Covered in the Report 65
7.3 Secondary Research 67
7.4 Primary Research 67
7.5 Models 68
7.6 Forecasts 68
7.7 Expert Panel Validation 68
7.8 Currency Conversion 69
7.9 Contact Us 69
7.10 Disclaimer 69
For more information visit http://www.researchandmarkets.com/research/68bj8d/finland_diabetes
